Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Antman, K' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 40 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Vahdat, L; Papadopoulos, K; Lange, D; Leuin, S; Kaufman, E; Donovan, D; Frederick, D; Bagiella, E; Tiersten, A; Nichols, G; Garrett, T; Savage, D; Antman, K; Hesdorffer, CS; Balmaceda, C
      Reduction of paclitaxel-induced peripheral neuropathy with glutamine

      CLINICAL CANCER RESEARCH
    2. Antman, K; Benson, MC; Chabot, J; Cobrinik, D; Grann, VR; Jacobson, JS; Joe, AK; Katz, AE; Kelly, K; Neugut, AI; Russo, D; Tiersten, A; Weinstein, IB
      Complementary and alternative medicine: The role of the cancer center

      JOURNAL OF CLINICAL ONCOLOGY
    3. Antman, K; Lagakos, S; Drazen, J
      Designing and funding clinical trials of novel therapies.

      NEW ENGLAND JOURNAL OF MEDICINE
    4. Antman, K; Chang, Y
      Kaposi's sarcoma - Reply

      NEW ENGLAND JOURNAL OF MEDICINE
    5. Antman, K; Chang, Y
      Kaposi's sarcoma

      NEW ENGLAND JOURNAL OF MEDICINE
    6. Moslehi, R; Russo, D; Phelan, C; Jack, E; Antman, K; Narod, S
      An unaffected individual from a breast/ovarian cancer family with germlinemutations in both BRCA1 and BRCA2

      CLINICAL GENETICS
    7. Antman, K; Shea, S
      Screening mammography for women younger than 50 years - Reply

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    8. Antman, K; Shea, S
      Screening mammography under age 50

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    9. VAHDAT LT; PAPADOPOULOS K; BALMACEDA C; MCGOVERN T; DUNLEAVY J; KAUFMAN E; FUNG B; GARRETT T; SAVAGE D; TIERSTEN A; AYELLO J; BAGIELLA E; HEITJAN D; ANTMAN K; HESDORFFER C
      PHASE-I TRIAL OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY WITH ESCALATING DOSE PACLITAXEL, MELPHALAN, AND CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN WITH PERIPHERAL-BLOOD PROGENITOR SUPPORT IN WOMEN WITH RESPONDING METASTATIC BREAST-CANCER

      Clinical cancer research
    10. FRANK TS; MANLEY SA; OLOPADE OI; CUMMINGS S; GARBER JE; BERNHARDT B; ANTMAN K; RUSSO D; WOOD ME; MULLINEAU L; ISAACS C; PESHKIN B; BUYS S; VENNE V; ROWLEY PT; LOADER S; OFFIT K; ROBSON M; HAMPEL H; BRENER D; WINER EP; CLARK S; WEBER B; STRONG LC; RIEGER P; MCCLURE M; WARD BE; SHATTUCKEIDENS D; OLIPHANT A; SKOLNICK MH; THOMAS A
      SEQUENCE-ANALYSIS OF BRCA1 AND BRCA2 - CORRELATION OF MUTATIONS WITH FAMILY HISTORY AND OVARIAN-CANCER RISK

      Journal of clinical oncology
    11. AYASH LJ; ELIAS A; IBRAHIM J; SCHWARTZ G; WHEELER C; REICH E; LYNCH C; WARREN D; SHAPIRO C; RICHARDSON P; HURD D; SCHNIPPER L; FREI E; ANTMAN K
      HIGH-DOSE MULTIMODALITY THERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT FORSTAGE IIIB BREAST-CARCINOMA

      Journal of clinical oncology
    12. ANTMAN K
      HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT FOR BREAST-CANCER IN NORTH-AMERICA - REPLY

      Journal of clinical oncology
    13. HESDORFFER C; AYELLO J; WARD M; KAUBISCH A; VAHDAT L; BALMACEDA C; GARRETT T; FETELL M; REISS R; BANK A; ANTMAN K
      PHASE-I TRIAL OF RETROVIRAL-MEDIATED TRANSFER OF THE HUMAN MDR1 GENE AS MARROW CHEMOPROTECTION IN PATIENTS UNDERGOING HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION

      Journal of clinical oncology
    14. ANTMAN K; CROWLEY J; BALCERZAK SP; KEMPF RA; WEISS RB; CLAMON GH; BAKER LH
      A SOUTHWEST-ONCOLOGY-GROUP AND CANCER AND LEUKEMIA GROUP-B PHASE-II STUDY OF DOXORUBICIN, DACARBAZINE, IFOSFAMIDE, AND MESNA IN ADULTS WITHADVANCED OSTEOSARCOMA, EWINGS-SARCOMA, AND RHABDOMYOSARCOMA

      Cancer
    15. KEOHAN ML; GREVER MR; BALCERZAK SP; ANTMAN K
      A PHASE-II SOUTHWEST-ONCOLOGY-GROUP STUDY OF CISPLATIN AND CONTINUOUS-INFUSION VINBLASTINE IN THE TREATMENT OF ADVANCED SOFT-TISSUE SARCOMA

      Investigational new drugs
    16. TIERNEY JF; STEWART LA; PARMAR MKB; FLETCHER CDM; JONES G; MOSSERI V; PATEL M; DEELVIRA MCR; SOUHAMI RL; SYLVESTER R; TURSZ T; ALVEGARD TA; SIGURDSSON H; ANTMAN K; BACCHI M; BAKER LH; BENJAMIN RS; BRADY MF; BRAMWELL V; BUI BN; EDMONSON JH; LEYVRAZ S; OMURA GA; ROUESSE J; RYAN L; VANOOSTEROM AT; YANG JC
      ADJUVANT CHEMOTHERAPY FOR LOCALIZED RESECTABLE SOFT-TISSUE SARCOMA OFADULTS - METAANALYSIS OF INDIVIDUAL DATA

      Lancet
    17. SHERMAN W; BALMACEDA C; NICHOLS G; MEARS G; ANTMAN K
      FEASIBILITY OF 3 G M2 OF INTRAVENOUS METHOTREXATE (IVMTX) FOR PRIMARYCENTRAL-NERVOUS-SYSTEM LYMPHOMA (PCNSL)/

      Neurology
    18. BALMACEDA C; HESDORFFER C; PAPPADOUPOLOUS K; SIMMONS T; VAHDAT L; GARRET T; ANTMAN K; FETELL MR
      FEASIBILITY OF HIGH-DOSE CHEMOTHERAPY (HDC) FOLLOWED BY AUTOLOGOUS ORSTEM-CELL SUPPORT FOR RECURRENT PROGRESSIVE OLIGODENDROGLIOMA(O)/

      Neurology
    19. FRANK TS; MANLEY S; THOMAS A; MCCLURE M; WARD BE; SHATTUCKEIDENS D; OLIPHANT A; ANTMAN K; BERNHARDT B; BUYS S; CUMMINGS S; EDGE S; FARRELL C; GARBER J; ISAACS C; LOADER S; OFFIT K; OLOPADE F; PESHKIN B; ROWLEY P; RUSSO D; STRONG L; VENNE V; WEBER B; WINER E; WOOD M; WOOD WC; SKOLNICK M
      BRCA1 AND BRCA1 SEQUENCE-ANALYSIS OF 335 HIGH-RISK WOMEN

      American journal of human genetics
    20. AYASH LJ; ELIAS A; SCHWARTZ G; WHEELER C; IBRAHIM J; TEICHER BA; REICH E; WARREN D; LYNCH C; RICHARDSON P; SCHNIPPER L; FREI E; ANTMAN K
      DOUBLE DOSE-INTENSIVE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT FOR METASTATIC BREAST-CANCER - NO IMPROVEMENT IN PROGRESSION-FREE SURVIVAL BY THE SEQUENCE OF HIGH-DOSE MELPHALAN FOLLOWED BY CYCLOPHOSPHAMIDE, THIOTEPA, AND CARBOPLATIN

      Journal of clinical oncology
    21. ANTMAN K
      WHEN ARE BONE-MARROW TRANSPLANTS CONSIDERED

      Scientific American
    22. AYASH LJ; WHEELER C; FAIRCLOUGH D; SCHWARTZ G; REICH E; WARREN D; SCHNIPPER L; ANTMAN K; FREI E; ELIAS A
      PROGNOSTIC FACTORS FOR PROLONGED PROGRESSION-FREE SURVIVAL WITH HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM-CELL SUPPORT FOR ADVANCED BREAST-CANCER

      Journal of clinical oncology
    23. ANTMAN K
      PRESIDENTIAL-ADDRESS - MAY 22, 1995 - 31ST ANNUAL-MEETING OF THE AMERICAN-SOCIETY-OF-CLINICAL-ONCOLOGY

      Journal of clinical oncology
    24. WRIGHT JE; ELIAS A; TRETYAKOV O; HOLDEN S; ANDERSEN J; WHEELER C; SCHWARTZ G; ANTMAN K; ROSOWSKY A; FREL E; AYASH LJ
      HIGH-DOSE IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE PHARMACOKINETICS - CORRELATION OF PLASMA DRUG LEVELS WITH RENAL TOXICITY

      Cancer chemotherapy and pharmacology
    25. VAHDAT L; ANTMAN K
      HIGH-DOSE THERAPY FOR BREAST-CANCER

      Blood reviews
    26. BENJAMIN RJ; LINSLEY L; AXELROD JD; CHURCHILL WH; SIEFF C; SHULMAN LN; ELIAS A; AYASH L; MALACHOWSKI ME; UHL L; GAYNES L; MCCAULEY M; THOMPSON L; MAZANET R; ANTMAN K; SCHNIPPER L; TEPLER I; ANTIN JH; WHEELER C
      THE COLLECTION AND EVALUATION OF PERIPHERAL-BLOOD PROGENITOR CELLS SUFFICIENT FOR REPETITIVE CYCLES OF HIGH-DOSE CHEMOTHERAPY SUPPORT

      Transfusion
    27. BISHOP JM; CALABRESI P; ANTMAN K; BALTIMORE D; FOLKMAN J; LIVINGSTONE DM; MINNA JD; PICKETT CB; ROSENBERG L; STRONG LC; VOGELSTEIN B; WELLS SA; RIMER BK; KALT M; SONDIK EJ
      NCI INTRAMURAL PROGRAM REVIEW COMPLETE - PUBLIC COMMENT SOUGHT ON RECOMMENDATIONS

      Journal of the National Cancer Institute
    28. HESDORFFER C; ANTMAN K; BANK A; FETELL M; MEARS G; BEGG M
      CLINICAL PROTOCOL - HUMAN MDR GENE-TRANSFER IN PATIENTS WITH ADVANCEDCANCER

      Human gene therapy
    29. AYASH LJ; ELIAS A; WHEELER C; REICH E; SCHWARTZ G; MAZANEF R; TEPLER I; WARREN D; LYNCH C; GONIN R; SCHNIPPER L; FREI E; ANTMAN K
      DOUBLE DOSE-INTENSIVE CHEMOTHERAPY WITH AUTOLOGOUS MARROW AND PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT FOR METASTATIC BREAST-CANCER - A FEASIBILITY STUDY

      Journal of clinical oncology
    30. AYASH LJ; ELIAS A; HUNT M; DEMETRI G; WHEELER C; TEPLER I; SCHWARTZ G; MAZANET R; REICH E; MCCAULEY M; ANTMAN K; ANDERSON KC
      RECOMBINANT-HUMAN-ERYTHROPOIETIN FOR THE TREATMENT OF THE ANEMIA ASSOCIATED WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      British Journal of Haematology
    31. WEBB IJ; AYASH LJ; EICKHOFF CE; WHEELER C; SCHWARTZ G; MAZANET R; DEMETRI G; ANTMAN K; SCHNIPPER L; FREI E; ELIAS A
      STRATEGIES FOR MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS FOR USE INHIGH-DOSE CHEMOTHERAPY

      Blood
    32. CHAHINIAN AP; ANTMAN K; GOUTSOU M; CORSON JM; SUZUKI Y; MODEAS C; HERNDON JE; AISNER J; ELLISON RR; LEONE L; VOGELZANG NJ; GREEN MR
      RANDOMIZED PHASE-II TRIAL OF CISPLATIN WITH MITOMYCIN OR DOXORUBICIN FOR MALIGNANT MESOTHELIOMA BY THE CANCER AND LEUKEMIA GROUP-B

      Journal of clinical oncology
    33. ANTMAN K; CROWLEY J; BALCERZAK SP; RIVKIN SE; WEISS GR; ELIAS A; NATALE RB; COOPER RM; BARLOGIE B; TRUMP DL; DOROSHOW JH; AISNER J; PUGH RP; WEISS RB; COOPER BA; CLAMOND GH; BAKER LH
      AN INTERGROUP PHASE-III RANDOMIZED STUDY OF DOXORUBICIN AND DACARBAZINE WITH OR WITHOUT IFOSFAMIDE AND MESNA IN ADVANCED SOFT-TISSUE AND BONE SARCOMAS

      Journal of clinical oncology
    34. WHEELER C; STRAWDERMAN M; AYASH L; CHURCHILL WH; BIERER BE; ELIAS A; GILLILAND DG; ANTMAN K; GUINAN EC; EDER JP; WEINSTEIN H; SCHWARTZ G; FERRARA J; MAZANET R; RIMM IJ; TEPLER I; MCCARTHY P; MAUCH P; AULT K; GAYNES L; MCCAULEY M; SCHNIPPER LE; ANTIN J
      PROGNOSTIC FACTORS FOR TREATMENT OUTCOME IN AUTOTRANSPLANTATION OF INTERMEDIATE-GRADE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA WITH CYCLOPHOSPHAMIDE, CARMUSTINE, AND ETOPOSIDE

      Journal of clinical oncology
    35. PRESTIFILIPPO J; ANTMAN K; BERKMAN BJ; KAUFMAN D; LANTOS J; LAWRENCE W; LEVINE RJ; MCKENNA RJ
      THE ETHICAL TREATMENT OF CANCER - WHAT IS RIGHT FOR THE PATIENT - DISCUSSION

      Cancer
    36. LAWRENCE W; ANTMAN K; FREEMAN HP; HUBER SL; KAUFMAN D; LANTOS J; LENHARD RE; LEVINE RJ; MCKENNA RJ; YOUNG FE
      THE IMPACT OF CLINICAL-TRIAL PROTOCOLS ON PATIENT-CARE SYSTEMS - DISCUSSION

      Cancer
    37. ANTMAN K
      REIMBURSEMENT ISSUES FACING PATIENTS, PROVIDERS, AND PAYERS

      Cancer
    38. MURPHY GP; PRESTIFILIPPO J; ANTMAN K; BERKMAN BJ; HUBER SL; KAUFMAN D; KNOX WA; LAWRENCE W; LEVINE RJ; YOUNG FE
      THE ECONOMIC-IMPACT OF THERAPY ON CANCER-PATIENTS - DISCUSSION

      Cancer
    39. WHEELER C; SHULMAN LN; ELIAS A; AXELROD J; SIEFF C; CHURCHILL WH; AYASH L; GAYNES L; MCCAULEY M; THOMPSON L; MAZANET R; ANTMAN K; TEPLER I; SCHNIPPER L; WEGNER S; SCHWARTZ G; ANTIN JH
      SEQUENTIAL IFOSFAMIDE (I), CARBOPLATIN (C), AND ETOPOSIDE (E) WITH STEROIDS AND CYCLOPHOSPHAMIDE G-CSF MOBILIZED PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT (SPICE) IN RELAPSED LYMPHOMA/

      Blood
    40. DEMETRI GD; BUKOWSKI RM; SAMUELS B; GORDON M; ANTMAN K; MERICA EA; SAMUEL S; CAMPION M; LEVITT D; ISAACS R
      STIMULATION OF THROMBOPOIESIS BY RECOMBINANT HUMAN INTERLEUKIN-6 (IL-6) PRE-CHEMOTHERAPY AND POSTCHEMOTHERAPY IN PREVIOUSLY UNTREATED SARCOMA PATIENTS WITH NORMAL HEMATOPOIESIS

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/01/21 alle ore 07:44:05